series-c-plus
Stage
2
Investors
About
Horizon Discovery develops gene editing and gene modulation tools and services that enable research institutions, biotech, and pharmaceutical companies to investigate genetic drivers of disease, develop diagnostics, and advance precision medicine therapies.
Explore Horizon Discovery's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.